Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Aydin et al .

Autor:	Freites Nuñez DD; Rheumatology Unit, Hospital Clínico San Carlos,IdISSC, Madrid, Spain., Leon L; Rheumatology Unit, Hospital Clínico San Carlos,IdISSC, Madrid, Spain lleon.hcsc@salud.madrid.org.; Health Sciences, Camilo Jose Cela University, Villafranca del Castillo, Comunidad de Madrid, Spain., Mucientes A; Rheumatology Unit, Hospital Clínico San Carlos,IdISSC, Madrid, Spain., Rodriguez-Rodriguez L; Rheumatology Unit, Hospital Clínico San Carlos,IdISSC, Madrid, Spain., Font Urgelles J; Rheumatology Unit, Hospital Clínico San Carlos,IdISSC, Madrid, Spain., Madrid García A; Rheumatology Unit, Hospital Clínico San Carlos,IdISSC, Madrid, Spain., Colomer JI; Rheumatology Unit, Hospital Clínico San Carlos,IdISSC, Madrid, Spain., Jover JA; Rheumatology Unit, Hospital Clínico San Carlos,IdISSC, Madrid, Spain., Fernandez-Gutierrez B; Rheumatology Unit, Hospital Clínico San Carlos,IdISSC, Madrid, Spain., Abasolo L; Rheumatology Unit, Hospital Clínico San Carlos,IdISSC, Madrid, Spain.
Jazyk:	angličtina
Zdroj:	Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Mar; Vol. 82 (3), pp. e70. Date of Electronic Publication: 2020 Dec 18.
DOI:	10.1136/annrheumdis-2020-219580
Abstrakt:	Competing Interests: Competing interests: None declared.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu